Individual QT Correction
Showing 1 - 25 of >10,000
Qt Interval, Variation in Trial in Sunderland (Intermittent graded exercise test)
Suspended
- Qt Interval, Variation in
- Intermittent graded exercise test
-
Sunderland, Tyne And Wear, United KingdomSunderland University
Dec 21, 2021
Asthma, COPD (COPD) Trial in Baltimore (CHF5993, CHF5259, Moxifloxacin 400mg)
Recruiting
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- CHF5993
- +3 more
-
Baltimore, MarylandPAREXEL Baltimore Early Phase Clinical Unit
Apr 13, 2023
Cardiac Arrhythmias Trial in Boston (Moxifloxacin 400mg once time)
Terminated
- Cardiac Arrhythmias
- Moxifloxacin 400mg once time
-
Boston, MassachusettsMassachusetts General Hospital
Dec 23, 2021
Stroke Rehabilitation Trial in Moscow (Multimodal technology (MT), Conventional rehabilitation (CR))
Recruiting
- Stroke Rehabilitation
- Multimodal technology (MT)
- Conventional rehabilitation (CR)
-
Moscow, Russian FederationMoscow Scientific and Practical Center of Medical Rehabilitation
Jul 27, 2022
Torsades de Pointe Caused by Drug, Long QT Syndrome Trial in Saint Louis (BodyGuardian Heart)
Not yet recruiting
- Torsades de Pointe Caused by Drug
- Long QT Syndrome
- BodyGuardian Heart
-
Saint Louis, MissouriWashington University School of Medicine
Jan 17, 2023
QT Intervals Changes, QTc Intervals Changes Trial in Leeds (Omecamtiv Mecarbil (OM), Placebo, Moxifloxacin)
Completed
- QT Intervals Changes
- QTc Intervals Changes
- Omecamtiv Mecarbil (OM)
- +2 more
-
Leeds, United KingdomResearch Site
Nov 2, 2021
Osteoarthritis, Knee, Knee Pain Chronic, Arthralgia Trial (Procedure: HTO using PSI aiming at 55% correction, Procedure: HTO
Not yet recruiting
- Osteoarthritis, Knee
- +2 more
- Procedure: HTO using PSI aiming at 55% correction
- Procedure: HTO using PSI aiming at 62% correction
- (no location specified)
Nov 10, 2023
Healthy Trial in New Haven (PF-07328948, Placebo)
Recruiting
- Healthy
- PF-07328948
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jan 5, 2023
Adolescent Idiopathic Scoliosis, Scoliosis Idiopathic Trial in Giza (vertebral derotation)
Recruiting
- Adolescent Idiopathic Scoliosis
- Scoliosis Idiopathic
- vertebral derotation
-
Giza, Egypt
- +1 more
Mar 28, 2023
Temporomandibular Disorder, Forward Head Posture Trial in Sharjah (Denneroll cervical traction orthodontic, stretching and
Not yet recruiting
- Temporomandibular Disorder
- Forward Head Posture
- Denneroll cervical traction orthodontic
- +2 more
-
Sharjah, United Arab EmiratesUniversity of Sharjah
Nov 8, 2023
Anterior Knee Pain Syndrome, Pronated Foot Trial in Abu Dhabi (Manual Therapy)
Recruiting
- Anterior Knee Pain Syndrome
- Pronated Foot
- Manual Therapy
-
Abu Dhabi, United Arab EmiratesMediclinic Al Noor Hospital
Jun 23, 2023
ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer Trial in Luoyang, Shanghai (TFX06 tablet)
Recruiting
- ER+, HER2- Advanced Breast Cancer
- Metastatic Breast Cancer
- TFX06 tablet
-
Luoyang, Henan, China
- +1 more
Jun 25, 2023
Non-alcoholic Steatohepatitis Trial in Berlin (Cotadutide, Cotadutide-, Moxifloxacin)
Recruiting
- Non-alcoholic Steatohepatitis
- Cotadutide
- +3 more
-
Berlin, GermanyResearch Site
Jan 16, 2023
HSV Infection Trial in London (Pritelivir and moxifloxacin , Pritelivir , moxifloxacin and moxifloxacin , Pritelivir ,
Recruiting
- HSV Infection
- Pritelivir and moxifloxacin placebo
- +2 more
-
London, United KingdomRichmond Pharmacology Ltd
Jan 3, 2023
Postpartum Hemorrhage Trial in Tempe (Carbetocin, Placebo, Placebo and Moxifloxacin)
Recruiting
- Postpartum Hemorrhage
- Carbetocin
- +2 more
-
Tempe, ArizonaFerring Investigational Site
Jun 20, 2023
Healthy Volunteers Trial in Tempe (Epetraborole and matching , Epetraborole, Placebo)
Active, not recruiting
- Healthy Volunteers
- Epetraborole and matching placebo
- +3 more
-
Tempe, Arizona423001
Aug 16, 2023
Temporomandibular Disorder, Forward Head Posture Trial in Sharjah (Conservative with Denneroll, Conservative, Dental management)
Not yet recruiting
- Temporomandibular Disorder
- Forward Head Posture
- Conservative with Denneroll
- +2 more
-
Sharjah, United Arab EmiratesUniversity of Sharjah
Nov 24, 2023
Healthy Subjects Trial in Phoenix (1.25 mg/kg BL-8040 + BL-8040-matching , 2 mg/kg BL-8040, BL-8040-matching )
Completed
- Healthy Subjects
- 1.25 mg/kg BL-8040 + BL-8040-matching placebo
- +3 more
-
Phoenix, ArizonaCelerion
Jan 1, 2023
Genetics of QT Prolongation With Antiarrhythmics
Recruiting
- Long QT Syndrome
- Drug Toxicity
- Dofetilide and/or sotalol
-
Aurora, Colorado
- +4 more
Mar 25, 2022